Steun het IDF Support IDF Steun het Diabetesfonds Check for Obesitas and Diabetes! Word bewust van Obesitas & Diabetes!
About: Dokter on line
· Snel · Voordelig · Discrete verzending . Erkende Artsen · Authentieke medicijnen · De grootste online -apotheek · Geen afspraak nodig · Vertrouwelijk en veilig · Geen wachtkamer · Bestel thuis of op het werk · 20% korting op sommige kosten voor trouwe klanten!
http://nl.dokteronline.com/669/coupon/C1070674/ Met de coupon code krijgt u extra 10 euro korting! Deze actie is alleen via deze blog, en nergens anders verkrijgbaar. Let op: als u naar bestellen gaat bij het product van uw keuze dan ziet u de korting onder COUPON rechts. U krijgt deze bovenop de al geldende acties en aanbiedingen! en profiteert dus dubbel!
Het lichaam maakt zelf helemaal geen insuline meer aan.
Het afweersysteem heeft per ongeluk de cellen die insuline aanmaken vernietigd.
Mensen met diabetes type 1 moeten een paar keer per dag zichzelf insuline inspuiten, of een insulinepomp dragen.
Heette vroeger ook wel 'jeugddiabetes'.
1 op de 10 mensen met diabetes heeft diabetes type 1.
Iemand met diabetes type 1 maakt zelf helemaal geen insuline meer aan. Zonder insuline kan het lichaam de bloedsuikerspiegel niet normaal houden en kan die gevaarlijk hoog oplopen. Diabetes type 1 ontstaat meestal in korte tijd en over het algemeen bij mensen onder de dertig jaar. Daarom heette diabetes type 1 vroeger ook wel 'jeugddiabetes'. Maar we weten nu dat je het op alle leeftijden nog kunt krijgen.
Diabetes type 1 is een auto-immuunziekte. Dat betekent dat het eigen afweersysteem het probleem heeft veroorzaakt. Normaal ruimt het afweersysteem alleen schadelijke indringers op in het lichaam. Bij diabetes type 1 heeft het afweersysteem per ongeluk de cellen die insuline aanmaken aangevallen. Daarom moet iemand met diabetes type 1 zelf insuline inspuiten om te kunnen leven.
We weten nog niet hoe je diabetes type 1 kunt voorkomen. Eerst moet de oorzaak van diabetes type 1 duidelijk zijn. De basis ligt wel bij een genetische vatbaarheid voor dit type diabetes. Maar of het tot diabetes komt, hangt af van een samenloop van omstandigheden.
Er zijn waarschijnlijk allerlei dingen die het afweersysteem in de war kunnen brengen waardoor diabetes type 1 de kop op steekt. Dat kan overigens ook nog op hoge leeftijd gebeuren en niet alleen bij kinderen. Mogelijk gaat het om bepaalde voedingsstoffen, zoals gluten, die bij sommige mensen tot een reactie leiden. Maar het lijkt er ook op dat een gewone virusinfectie de prikkel kan zijn bij mensen die genetische aanleg hebben om diabetes type 1 te krijgen.
Wanneer iemand met diabetes ziek is door een virus, zoals verkoudheid of buikgriep, dan stijgt vaak de bloedsuikerspiegel. Iemand moet meestal wat extra insuline spuiten, maar altijd in overleg met arts of verpleegkundige.
Onderzoek
De afgelopen tijd is het onderzoek naar diabetes type 1 in een stroomversnelling geraakt. Genezing komt steeds dichterbij! Voorbeelden van lopend onderzoek:
Lopend onderzoek beenmergcellen als reparatieploeg
Diabetes type 1
2003.01.008
Lopend
Dr. E.J.P. de Koning
€ 328.320
Bij diabetes type 1 zijn de insulineproducerende cellen (bètacellen) vernietigd of beschadigd.
Kunnen uit beenmerg afkomstige cellen een rol spelen in de reparatie van beschadigde bètacellen in de eilandjes van Langerhans en daarmee de behandeling verbeteren?
De afweervergissing stap voor stap volgen
Diabetes type 1
2007.00.020
Lopend
Prof. dr. B.O. Roep
€ 257.844
Eerder ontdekten deze onderzoekers precies welke cellen van het afweersysteem diabetes type 1 veroorzaken. Nu kijken ze verder:
hoe gedragen deze T-cellen zich precies in dat proces? Hoe gaat, stapje voor stapje, de vernietiging van insulineproducerende cellen in zijn werk?
Diabetes voorkomen via de darmen
Diabetes type 1
2007.00.069
Lopend
Dr. N.A. Bos
€ 266.268
Sinds kort is er het nieuwe idee dat bacteriën in de dikke darm een rol spelen bij het ontstaan van diabetes type 1.
De onderzoekers in dit project willen nagaan of bepaalde voeding en antibiotica de bacteriën in de darm kunnen veranderen. Dat zou het ontstaan van diabetes type 1 misschien vertragen of voorkomen.
Diabetes type 1 en de darmen
Het Universitair Medisch Centrum Groningen doet onderzoek naar de rol van de darmen bij het ontstaan van diabetes type 1. Het onderzoek wordt betaald door het Diabetes Fonds. Onderzoeker dr. Jeroen Visser legt uit over diabetes en darmen.
Onze darmen zijn onmisbaar om gezond te blijven. Ze zorgen ervoor dat schadelijke stoffen niet door de darmwand heen naar binnen kunnen. Bij sommige mensen met diabetes type 1 heeft de darmwand mogelijk wél meer stoffen doorgelaten dan zou moeten.
Via een afweerreactie van hun lichaam kon diabetes type 1 mogelijk ontstaan.
Salmonella en virussen
Hoe komt het dat de darmwand die stoffen heeft doorgelaten? Kortgeleden is ontdekt dat mensen met diabetes type 1 extra veel van het eiwit ‘zonuline’ in hun bloed hebben. Dat eiwit zorgt ervoor dat de cellen die de darmwand bekleden, minder hecht aan elkaar plakken. Met als gevolg een verhoogde doorlaatbaarheid van de darmwand.
Visser vat samen: “We weten dat sommige bacteriën de darm aanzetten tot het maken van zonuline; de ene bacterie doet dat meer dan de andere. De samenstelling van de darmflora heeft invloed op de aanmaak van zonuline en de doorlaatbaarheid van de darmwand. Ongezonde bacteriën zoals de bekende Salmonella maken de darmwand meer doorlaatbaar en ‘goede’ bacteriën zoals lactobacillen maken de darmwand minder doorlaatbaar. Ook een bepaalde groep virussen: de ‘enterovirussen’, kunnen slecht zijn voor de darmwand. Van een enterovirus merk je soms nauwelijks wat, en soms worden mensen heel ziek. Daarnaast kunnen gluten ook de aanmaak van zonuline stimuleren en de darmwand meer doorlaatbaar maken. Hierdoor kunnen antigenen het lichaam in, en het afweersysteem in actie brengen.
Jeroen Visser denkt dat als je darmwand minder doorlaatbaar maakt, het afweersysteem minder wordt blootgesteld aan de stoffen en omstandigheden die diabetes type 1 kunnen oproepen. De afweerreactie zal dan minder zijn, waardoor geen diabetes type 1 ontstaat, of pas later.
Visser: “Die doorlaatbaarheid van de darmwand kun je indirect beïnvloeden door speciale voeding of verandering van de darmflora. Of met medicijnen die de werking van zonuline blokkeren. Dat wordt uitgezocht in een door het Diabetes Fonds gefinancierd onderzoek.
Baby Luiers
Op dit moment loopt er een groot internationaal onderzoek bij jonge kinderen naar de invloed van voeding op het ontstaan van diabetes type 1. Dit onderzoek wordt eveneens deels betaald door het Diabetes Fonds. De hoop en voorzichtige verwachting is dat de baby’s die naast borstvoeding alleen speciale hypoallergene babyvoeding zonder koemelkeiwit krijgen, een derde minder kans hebben op diabetes. In Groningen gaat een heel team van onderzoekers de volle luiers onderzoeken van de deelnemende baby’s, om te kijken hoe groot het verband is tussen darmflora en de kans op het krijgen van diabetes type 1. Dergelijk onderzoek kan heel belangrijk zijn voor nieuwe behandelingen en adviezen ter voorkoming en genezing van diabetes type 1.
Dit artikel verscheen in het blad Dialoog van het Diabetes Fonds, 2009
Vraag en antwoordover darmflora onderzoek
Momenteel wordt onderzocht wat de rol is van de darmen en voeding op het ontstaan van diabetes type 1. Hier vindt u vragen en antwoorden.
Is speciale babyvoeding zonder hele koemelkeiwitten minder gezond?
Nee, de speciale babyvoeding bevat alle nodige voedingsstoffen.
Moeten ouders nu opletten met voeding van baby's en kinderen, zo ja wat kun je nu al doen zonder dat het kwaad kan?
Het beste advies is om als het even kan borstvoeding te geven. Het liefst zes maanden, dat verkleint ook de kans op allergieën bij het kind. Eventueel gevolgd door een hypoallergene babyvoeding tot de leeftijd van 1 jaar. Bijvoeding bij de borstvoeding vanaf de 5e maand is dan prima. Maar het is echt niet zo dat een kind zonder borstvoeding dan zeker een allergie krijgt of een autoimmuunziekte zoals diabetes type 1. De kans is alleen ietsje groter, maar nog steeds heel klein.
Hoeveel kleiner zou de kans op diabetes worden?
Als de uitkomsten van beide onderzoeken goed zijn (dus het onderzoek naar voeding en naar de darmflora) dan zou de kans op diabetes type 1 30 tot 50% kleiner kunnen worden.
Wanneer weten we meer over de uitkomsten van het onderzoek?
Over zo'n vijf jaar krijgen we de eerste uitkomsten. Het borstvoedingsonderzoek is al vijf jaar bezig maar duurt in totaal tien jaar, omdat de onderzoekers dan pas kunnen zien hoe het met alle kinderen gaat.
Maakt het voor mensen die al diabetes type 1 hebben uit of ze koemelkeiwit of gluten eten?
Dat moet verder worden uitgezocht, dat weten we nu nog niet. Er is wel een kans dat voeding invloed heeft op het ontstaan van bepaalde complicaties, zoals nierziekten, maar daar weten we nog te weinig over. het is wel belangrijk om dat verder uit te zoeken.
Hoe zit het met voedselvergiftiging of buikgriep?
Als salmonella de darm aanzet tot afgifte van zonuline, die de darmwand meer doorlaatbaar maakt, is het dan zo dat je risico loopt op diabetes type 1 of verergering ervan als je een voedselvergiftiging of ‘buikgriep' hebt?
Nee, daar zijn op dit moment geen bewijzen voor. Er speelt ook genetische aanleg mee bij de doorlaatbaarheid van de darm. Zowel bij mensen met diabetes type 1 als bij mensen met coeliakie zijn er afwijkingen in de genen die de doorlaatbaarheid regelen.
Kan doorlaatbaarheid van de darmwand ook nog leiden tot andere auto-immuunziekten?
Ja, zoals coeliakie (overgevoeligheid voor gluten). Daarnaast speelt het mogelijk een rol bij Reuma en MS. Het zou ook een factor kunnen zijn bij bepaalde autistische aandoeningen.
Wordt er wat gedaan met het verband tussen coeliakie en diabetes type 1?
Ja, er wordt nu in diverse landen, zoals de Verenigde Staten, aangeraden om kinderen met diabetes type 1 ook te onderzoeken op coeliakie. Want 4 tot 8 van de 100 kinderen met diabetes type 1 krijgt ook coeliakie.
Representatives of government health departments and patients' organizations from all European countries met with diabetes experts under the aegis of the WHO Europe and the IDF Europe in St Vincent, Italy, in October 1989. They unanimously agreed on general goals for people with diabetes and on a lot of five-year targets in the framework of the St Vincent Declaration (SVD).
‘Diabetes Care and Research in Europe: The St Vincent Declaration 1989’ and ‘Istanbul commitment 1999’.
In the nineties:
St Vincent became a real concept in the diabetes world
About 50 official national liaison people were appointed for the SVD Action Programme
About 15 working groups of the SVD Action Programme were set up
About 40 national diabetes action plans were formulated
European Meetings for the Implementation of SVD were organized (Hungary-1992, Greece-1995, Portugal-1997, Turkey-1999).
The EASD joined the St Vincent movement, and IDF/EASD co-operation continues to thrive today, as demonstrated by the EU 6th Framework Campaign.
For several reasons, including the organization of SVD, the outcome of improved recording of diabetes itself and of the complications (as mentioned in the SVD-targets), and the accessing good information about the progress of the national action plans were very difficult.
Since the meeting of the 10th anniversary of SVD in Istanbul (1999), the movement of SVD was very quiet for practical reasons and no meetings were organized. But at the same time WHO Europe, IDF Europe and EASD realized how important the concept of the St Vincent Declaration still is. Even stronger : SVD is more needed than ever. It is still used as a guide to national diabetes service developments. In addition, the epidemic growth of diabetes and the tremendous increase of complications and of the very serious socio-economic impact of diabetes in the many countries of the European Region of IDF and WHO demand a response at national and regional levels.
The blue circle is the universal symbol for diabetes. Find out why.
A global symbol for diabetes
The blue circle is the universal symbol for diabetes. The purpose of the diabetes symbol is to give diabetes a common identity.
The icon was originally developed in 2006 for the campaign for a United Nations Resolution on diabetes. The campaign was a response to the diabetes pandemic that is set to overwhelm healthcare resources everywhere. It mobilised diabetes stakeholders behind the common cause of securing a United Nations Resolution on diabetes. The United Nations passed Resolution 61/255 ‘World Diabetes Day’ on December 20 2006.
Until 2006, there was no global symbol for diabetes. The blue circle aims to:
Support all existing efforts to raise awareness about diabetes
Inspire new activities, and bring diabetes to the attention of the general public
Brand diabetes
Provide a means to show support for the fight against diabetes
Why a circle?
The circle occurs frequently in nature and has thus been widely employed since the dawn of humankind. The significance is overwhelmingly positive. Across cultures, the circle can symbolize life and health. Most significantly for the campaign, the circle symbolizes unity. Our combined strength is the key element that made this campaign so special. The global diabetes community came together to support a United Nations Resolution on diabetes and needs to remain united to make a difference. As we all know: to do nothing is no longer an option.
Why blue?
The blue border of the circle reflects the colour of the sky and the flag of the United Nations. The United Nations is in itself a symbol of unity amongst nations and is the only organization that can signal to governments everywhere that it is time to fight diabetes and reverse the global trends that will impede economic development and cause so much suffering and premature death.
Use of the symbol
The International Diabetes Federation (IDF) holds all rights to the blue circle symbol for diabetes. IDF encourages everyone to use the symbol for diabetes as a reference to diabetes and the millions of people affected by the disease. We welcome the use of the logo in publications: magazines, video, online information, etc.
The symbol cannot be used without prior permission by IDF. It cannot be used:
To promote or refer to anything other than diabetes
As a quality label
For merchandizing or any other form of commercial aim
While IDF holds all rights to the diabetes symbol, IDF can provide permission for merchandising carrying the diabetes symbol on a case-by-case basis. You can submit your proposal to diabetessymbol@idf.org.
The IDF Executive Office in Brussels is the focus of numerous requests for information about diabetes issues. These come from a range of sources, including the governments, industry, the media, Member Associations, and people with diabetes. The IDF staff and Officers are regularly asked to explain the position of the Federation with regards to subjects such as tobacco smoking or obesity. Information produced or gathered by IDF is processed into press copy or reproduced to support diabetes campaigns. In order to ensure the diffusion of accurate and relevant data, IDF produces position statements which summarize and describe the Federation's view on a number of topics. Anne Pierson reports.
0
1
2
3
4
5
- Gemiddelde waardering: 0/5 - (0 Stemmen) Tags:This is where we stand: the IDF position statements
Fact sheet Diabetes and obesity
Obesity and diabetes: the link
The prevalence of obesity is rising to epidemic proportions worldwide. In some countries, an astonishing half of the population is overweight. Being overweight or obese seriously increases an individual’s risk of developing other health problems such as type 2 diabetes, coronary heart disease, and some forms of cancer.
In both men and women, the more overweight an individual is, the greater the risk of developing type 2 diabetes. The means by which excessive body fat causes type 2 diabetes is not clearly defined, but it appears that excess fat increases insulin resistance, raising blood glucose levels and the likelihood of developing diabetes. People with a greater amount of abdominal fat have a higher risk of developing the condition.
Diabetes is the most preventable consequence of the obesity epidemic. Figures from the International Obesity Task Force (IOTF) suggest that up to 1.7 billion of the world’s population are already at a heightened risk of weight-related non-communicable diseases such as type 2 diabetes and cardiovascular disease. In fact, the risk in type 2 diabetes appears to be mainly related to the increasing prevalence of overweight and obese individuals worldwide. One in three Americans born today is predicted to develop diabetes as a consequence of obesity.
Prevention
Although obesity can affect anyone, the main risk factors are high-fat, high-energy dense diets and physical inactivity. Growing trends in many countries portray an ‘obesogenic’ society where the consumption of high-fat, high energy dense food is preferred to healthy fresh fruit and vegetables, and where the level of physical activity has dramatically been reduced or substituted by the constant usage of motor vehicles.
The importance of eating a low-fat, low-energy dense diet and participating in physical activity should be greatly promoted in order to reduce the risks of becoming overweight or obese. If these habits are introduced in children, there is a greater chance that they will continue into adulthood.
Public health programmes should stress the importance of a healthy environment, promoting improved diet and activity throughout communities. National programmes should be especially aimed at improving education and awareness of obesity and its consequences in schools and in youth recreational centres.
Treatment options
Weight management is the best strategy to prevent the development of type 2 diabetes. Research has shown that even a small amount of weight loss can decrease or slow down the risk of developing type 2 diabetes. Group therapy is advised to improve the psychological approach to weight loss, and to maintain an appropriate weight. Drugs to assist weight loss play a role in individuals for whom lifestyle changes alone may be insufficient to produce the required weight loss.
Facts
The prevalence of obesity is rising to epidemic proportions at an alarming rate in both developed and developing countries worldwide.
Overweight and obesity affect over half the world’s population and diabetes rates are climbing to 20% of all adults in many Middle Eastern, Asian, and Latin American countries.
Two thirds of adult men and women in the US with type 2 diabetes have a BMI of 27 or greater.
It is estimated that at least half of all diabetes cases would be eliminated if weight gain in adults could be prevented.
Non-communicable diseases such as diabetes now account for more deaths each year worldwide than AIDS.
The twin epidemics of obesity and diabetes already represent the biggest public health challenge of the 21st century.
Lifestyle interventions, including diet and moderate physical activity, can reduce the risk of developing type 2 diabetes by as much as 40-60%.
Public and professional awareness of the risk factors for and the symptoms of diabetes are an important step towards its control and prevention.
Diabetes prevention can be categorized into two groups:
Primary prevention
Secondary prevention
Primary prevention identifies and protects individuals at risk from developing diabetes. It therefore has an impact by reducing both the need for diabetes care and the need to treat diabetes-related complications.
While there is yet no conclusive evidence to suggest that type 1 diabetes can be prevented, primary prevention of type 2 diabetes is potentially possible.
Lifestyle changes aimed at weight control and increased physical activity are important objectives in the prevention of type 2 diabetes. The benefits of reducing body weight and increasing physical activity are not confined to type 2 diabetes; they also play a role in reducing heart disease, high blood pressure, etc.
Secondary prevention involves the early detection and prevention of complications, therefore reducing the need for treatment.
Action taken early in the course of diabetes is more beneficial in terms of quality of life and is more cost-effective, especially if this action can prevent hospitalization.
There is now conclusive evidence that good control of blood glucose levels can substantially reduce the risk of developing complications and slow their progression in all types of diabetes. The management of high blood pressure and raised blood lipids (fats) is equally important.
Prevention in developing countries
As the developing world is expected to bear the brunt of the escalating diabetes epidemic in the future, diabetes prevention is proving especially urgent and difficult in developing countries.
In most developing countries, health policies and services need to put more emphasis on non-communicable diseases such as diabetes, but in many of these countries (as well as in developed ones) decision-makers lack awareness of diabetes and the political will to invest in prevention.
The resources required for future research need to be found. Standards in diabetes monitoring and surveillance need to be set in countries where progress has been limited.
Individuals can experience different warning signs, and sometimes there may be no obvious warning, but some of the signs are commonly experienced:
Type 1 diabetes
The onset of type 1 diabetes is usually sudden and dramatic and can include symptoms such as:
Abnormal thirst and a dry mouth
Frequent urination
Extreme tiredness/lack of energy
Sudden weight loss
Slow-healing wounds
Recurrent infections
Blurred vision
Type 2 diabetes
The same symptoms that are listed above can also affect people with type 2 diabetes, but they are usually less obvious. The onset of type 2 diabetes is gradual and therefore hard to detect. Indeed, some people with type 2 diabetes show no obvious symptoms early on. These people are often diagnosed several years later, when various complications are already present.
People who think they might have diabetes should consult a healthcare professional.
0
1
2
3
4
5
- Gemiddelde waardering: 0/5 - (0 Stemmen) Tags:Why you should care
Types of diabetes
Types of diabetes
There are two main types of diabetes:
Type 1 diabetes is sometimes called insulin-dependent, immune-mediated or juvenile-onset diabetes. It is caused by an auto-immune reaction where the body’s defence system attacks the insulin-producing cells. The reason why this occurs is not fully understood. People with type 1 diabetes produce very little or no insulin. The disease can affect people of any age, but usually occurs in children or young adults. People with this form of diabetes need injections of insulin every day in order to control the levels of glucose in their blood. If people with type 1 diabetes do not have access to insulin, they die.
Type 2 diabetes is sometimes called non-insulin dependent diabetes or adult-onset diabetes. People with type 2 diabetes do not usually require injections of insulin. Usually they can control the glucose in their blood by watching their diet, taking regular exercise, oral medication, and possibly insulin.
Type 2 diabetes is most common in people older than 45 who are overweight. However, as a consequence of increased obesity among the young, it is becoming more common in children and young adults. Type 2 diabetes is the most common type of diabetes and accounts for 90-95% of all diabetes.
If people with type 2 diabetes are not diagnosed and treated, they can develop serious complications, which can result in an early death. Worldwide, many millions of people have type 2 diabetes without even knowing it. Others do not have access to adequate medical care. The onset of type 2 diabetes is also linked to genetic factors but obesity, physical inactivity and unhealthy diet increase the risks.
Some women develop a third, usually temporary, type of diabetes called ‘gestational diabetes’ when they are pregnant. Gestational diabetes develops in 2-5% of all pregnancies but usually disappears when the pregnancy is over. Women who have had gestational diabetes have an increased risk of developing type 2 diabetes later on.
Many adults have had diabetes for several years before their symptoms are recognised. By the time they are diagnosed, a great many have already started to develop the complications of diabetes - visual impairment, kidney failure, heart disease, stroke and nerve damage. In many parts of the world, people with diabetes are not diagnosed at all.
Spotting diabetes early means that it can be treated and the risk of the serious complications can be greatly reduced.
A number of factors contribute to the likelihood of someone developing diabetes.
Risk factors for type 1 diabetes:
These are not very well defined, but it would appear that genetic and environmental factors could trigger the development of this type of diabetes. If there is someone in your family who has diabetes, then your chances of developing the disease are increased.
Risk factors for type 2 diabetes:
Age
90-95% of people with diabetes have type 2 diabetes. This type usually occurs in people over the age of 40 but is now also affecting children and adolescents to a greater extent. The older you are, the greater your risk of diabetes.
Obesity
Over 80 per cent of people with type 2 diabetes are overweight. The more overweight you are, the greater your risk of diabetes.
A family history of diabetes
Research has shown that people are more at risk if there is a history of diabetes in close family members. The closer the relative, the greater your risk of diabetes.
Physical inactivity
Research has shown that people who do not lead an active life are more at risk of developing type 2 diabetes. The less exercise you do, the greater your chances of developing diabetes.
Impaired glucose tolerance (IGT)
A healthy person’s blood sugar is usually between 70 and 110 mg/dL (milligrams of glucose in 100 millilitres of blood) or, in millimols, between 3.9 and 6.0 mmol/L. Impaired glucose tolerance is a level of blood glucose which is higher than normal, but not high enough to be in the range where doctors classify this as diabetes.
Race/ethnicity
As far as we know, race and ethnicity are important in determining the possibility of a person developing diabetes. Little research, however, has been undertaken outside of the United States. Within that population, African-Americans, Hispanic Americans, Native Americans, Asian-Americans and Pacific Islanders are more likely to have diabetes.
Diabetes during pregnancy
Some women develop a temporary type of diabetes called 'gestational diabetes' when they are pregnant. Gestational diabetes develops in 2-5% of all pregnancies, but usually disappears when the pregnancy is over. However, women who have had gestational diabetes or who have given birth to a large baby (4kg/2lb or greater) are at a greater risk of developing type 2 diabetes at a later stage in their lives.
If you think that are you are at risk of developing diabetes, you should talk to a healthcare professional.
EU Diabetes Policy Audit: following the success of the first report carried out in 2005 ('Diabetes - The Policy Puzzle: Towards Benchmarking in the EU 25'), a new edition has been published:
IDF Europe's comment on food labelling.
For further information on the European Region, please contact:
Lex Herrebrugh Regional Manager IDF Europe Chaussée de la Hulpe 166 B-1170 Brussels Belgium Tel: +32 2 5371889 Fax: +32 2 5371981 e-mail: info@idf-europe.org
When your cells become insulin resistant, they lose their sensitivity to insulin. As a result, large quantities of glucose cannot enter the cells, remaining instead, in the blood stream where it passes to the liver and is converted to fat. This process often leads to weight gain.
the 6th World Congress on Prevention of Diabetes and its Complications
Welcome
Welcome to Germany in 2010!
On behalf of the Local Organizing Committee it is my pleasure to invite you to participate in the 6th World Congress on Prevention of Diabetes and its Complications (WCPD 2010), to be held in Dresden, Germany on April 8-11, 2010.
We know that diabetes prevention is effective but diabetes prevention presents many different faces creating unknown challenges, such as medical and psychological, but also shows political, economical, social and environmental expressions. Currently we know numerous diabetes prevention concepts which can be implemented into clinical practice in various countries worldwide, but we lack the exchange of their ideas, experiences and often problems with management.
The 6th WCPD provides a great opportunity to enable a more effective communication between all people interested in diabetes prevention and its management. Here we have the opportunity to learn from the experiences of others especially discussing barriers encountered during prevention programme implementation. Our aim is to have the translation of what we have learned in Science into practical skills of prevention. We want to encourage the adoption of best practices in diabetes prevention involving a good partnership between all relevant players. Effective primary prevention is essential to reduce the epidemic of type 2 diabetes throughout the world. To achieve this, action is needed not only in the field of policy making but also in the development of targeted intervention programmes which address the needs of people with an increased risk of diabetes, clinical- and community-based healthcare professionals and the general population. In addition we have included other issues such as city planning aspects, funding opportunities and support for policy development because they affect the efficiency and efficacy of diabetes prevention programmes.
We are looking forward seeing you in Dresden in 2010!
Prof. Peter Schwarz President
Prof. Stefan Bornstein Vice President
World directory for people active in the prevention of diabetes –Register Today!
Our aim is to bring people world wide together interested in diabetes prevention. We invite everyone who is active in the prevention of diabetes and chronic diseases - medical professionals but also lay-people, politicians, administrators, public health specialists, health care providers and many, many others - to become a partner in the network.
We would like to establish an online world directory for “people active in diabetes prevention” to connect individuals who are interested and active in the field of prevention of diabetes mellitus.
This should help to:
build up a network of people being active in the prevention of diabetes worldwide
exchange information and experiences leading to successful implementation of prevention programs
With this network we would like to build a climate of understanding of success but also difficulties in the process of implementation.
If you are interested please go ahead and register with your name and Email address today. Step by step we would like to extend the information based on your inputs and responses.
Join the network "people active in diabetes prevention" and make the prevention of diabetes mellitus become reality.
IDF has three categories of association membership:
1. Provisional members
Between meetings of the General Council, associations may be admitted to provisional membership by the Board of Management upon the recommendation of the appropriate Regional Council.
At the next meeting of the General Council, provisional member associations are elected to full membership (provided they have been recommended by the Board of Management).
Provisional member associations pay an annual membership fee (equivalent to half of that which they would have to pay as a full member), for which they receive certain benefits.
Provisional members can appoint up to two observers to the General Council.
A full member association is any national association or society that is actively concerned with diabetes or diabetes-related conditions. An association is admitted to full membership by the General Council and pays an annual membership fee, which entitles it to special benefits.
Full members can appoint delegates to the General Council.
Full members may also nominate individuals for election to honorary membership.
Associate member associations are national or international associations actively concerned with issues related to diabetes and related conditions and affiliated to IDF. They are admitted to membership by the Executive Board upon the recommendation of the Board of Management.
Associate member associations pay an annual membership fee and may appoint one observer to the General Council.
Honorary Presidents and Honorary Members are elected by the General Council from among the candidates put forward by the Special Nominating Committee. There can be a maximum of 12 Honorary Presidents.
Honorary Presidents act as observers to the General Council.
Further information about IDF membership can be found in the IDF Articles of Association under Part II Membership, Article 4 to 9 and Part VII, Article 31.
If you have any additional questions regarding IDF membership please contact the IDF Executive Office.
'Het verlangen om medicijnen in te nemen is misschien het belangrijkste verschilpunt tussen de mens en het dier.' (Sir William Osler (1849-1919))
Blijf altijd op de hoogte van de ontwikkelingen op KimTube.nl. Krijg als eerste te horen wanneer er nieuwe filmpjes van Kim en haar geile vriendinnen online zijn!
klik Gratis Kim Holland Film en vul jouw email-adres in en je krijgt een gratis Kim Holland film kado!